Harbour Investments, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$34.2 - $47.56 $7,455 - $10,368	-218 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $195 - $407	7 Added 3.32%	218 $10,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $5,699 - $9,306	-221 Reduced 51.16%	211 $7,000
Q1 2021 Aug 17, 2021	BUY	$38.75 - $86.92 $16,701 - $37,462	431 Added 43100.0%	432 $18,000
Q1 2021 May 12, 2021	BUY	$38.75 - $86.92 $38 - $86	1 New	1 $0

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.